Last Updated: May 10, 2026

Details for New Drug Application (NDA): 021812

✉ Email this page to a colleague

NDA 021812 describes WOMEN'S ROGAINE, which is a drug marketed by Kenvue Brands and is included in one NDA. It is available from one supplier. Additional details are available on the WOMEN'S ROGAINE profile page.

The generic ingredient in WOMEN'S ROGAINE is minoxidil. There are eight drug master file entries for this compound. Eighty suppliers are listed for this compound. Additional details are available on the minoxidil profile page.

Summary for 021812

Tradename:	WOMEN'S ROGAINE
Applicant:	Kenvue Brands
Ingredient:	minoxidil
Patents:	0

Pharmacology for NDA: 021812

Physiological Effect	Arteriolar Vasodilation

Medical Subject Heading (MeSH) Categories for 021812

Antihypertensive Agents
Vasodilator Agents

Suppliers and Packaging for NDA: 021812

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
MEN'S ROGAINE	minoxidil	AEROSOL, FOAM;TOPICAL	021812	NDA	Kenvue Brands LLC	69968-0030	69968-0030-1	1 CAN in 1 CARTON (69968-0030-1) / 60 g in 1 CAN
MEN'S ROGAINE	minoxidil	AEROSOL, FOAM;TOPICAL	021812	NDA	Kenvue Brands LLC	69968-0030	69968-0030-2	2 CAN in 1 CARTON (69968-0030-2) / 60 g in 1 CAN

Profile for product number 001

Active Rx/OTC/Discontinued:	OTC	Dosage:	AEROSOL, FOAM;TOPICAL			Strength	5%
Approval Date:	Jan 20, 2006	TE:		RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	OTC	Dosage:	AEROSOL, FOAM;TOPICAL			Strength	5%
Approval Date:	Feb 28, 2014	TE:		RLD:	Yes

Expired US Patents for NDA 021812

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Kenvue Brands	MEN'S ROGAINE	minoxidil	AEROSOL, FOAM;TOPICAL	021812-001	Jan 20, 2006	⤷ Start Trial	⤷ Start Trial
Kenvue Brands	WOMEN'S ROGAINE	minoxidil	AEROSOL, FOAM;TOPICAL	021812-002	Feb 28, 2014	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.